Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test

被引:152
作者
O'Leary, Olivia F.
Bechtholt, Anita J.
Crowley, James J.
Hill, Tiffany E.
Page, Michelle E.
Lucki, Irwin
机构
[1] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA
[3] Natl Univ Ireland Univ Coll Galway, Dept Pharmacol, Galway, Ireland
关键词
antidepressant; SSRI; NRI; serotonin; norepinephrine; tail suspension test; behavior;
D O I
10.1007/s00213-007-0728-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Few studies have investiga. ted whether the behavioral effects elicited by different types of antidepressant drugs are mediated by either serotonin (5-HT) or the catecholamines norepinephrine (NE) and dopamine (DA). Objectives By depleting 5-HT, or NE and DA, the present study investigated the contributions of these monoamines to the acute behavioral effects of selective serotonin reuptake inhibitors (SSRIs; fluoxetine and citalopram) and norepinephrine reuptake inhibitors (NRIs; desipramine and reboxetine) in the mouse tail suspension test (TST). Results Depletion of 5-HT tissue content by para- chlorophenylalanine (PCPA), an inhibitor of tryptophan hydroxylase, completely blocked reductions of immobility by the SSRIs in the TST. In contrast, PCPA did not alter the behavioral effects of the NRIs. Inhibition of catecholamine synthesis by alpha-methyl-para-tyrosine (AMPT) reduced brain NE and DA tissue content, whereas disruption of vesicular storage with reserpine decreased brain NE, DA and 5-HT tissue content. However, neither treatment completely prevented responses to desipramine, fluoxetine, or citalopram in the TST. Depleting both newly synthesized and vesicular components of NE and DA transmission with a combination of reserpine and AMPT completely prevented the behavioral effects of desipramine, reboxetine, and fluoxetine and attenuated those of citalopram. Although PCPA did not alter baseline immobility, AMPT and reserpine increased baseline values in the TST. Conclusions These studies demonstrated that endogenous 5-HT synthesis mediates the behavioral effects of SSRIs, but not NRIs, in the TST. In contrast, disruption of the behavioral effects of NRI and SSRI antidepressants required disruption of both catecholamine synthesis and vesicular storage and release mechanisms.
引用
收藏
页码:357 / 371
页数:15
相关论文
共 79 条
[1]  
Arango V, 2002, PROG BRAIN RES, V136, P443
[2]   SUPPRESSION OF FIRING ACTIVITY OF 5-HT NEURONS IN THE DORSAL RAPHE BY ALPHA-ADRENOCEPTOR ANTAGONISTS [J].
BARABAN, JM ;
AGHAJANIAN, GK .
NEUROPHARMACOLOGY, 1980, 19 (04) :355-363
[3]  
Bechtholt AJ, 2006, RECEPTORS, P577
[4]  
BENKELFAT C, 1994, ARCH GEN PSYCHIAT, V51, P687
[5]   Effect of single and repeated administration of fluvoxamine on noradrenaline release in rat brain [J].
BenShachar, D ;
Klein, E ;
Tabak, A ;
Finberg, JPM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 332 (03) :237-243
[6]   Monoamine depletion in unmedicated depressed subjects [J].
Berman, RM ;
Sanacora, G ;
Anand, A ;
Roach, LM ;
Fasula, MK ;
Finkelstein, CO ;
Wachen, RM ;
Oren, DA ;
Heninger, GR ;
Charney, DS .
BIOLOGICAL PSYCHIATRY, 2002, 51 (06) :469-473
[7]   Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study [J].
Beyer, CE ;
Boikess, S ;
Luo, B ;
Dawson, LA .
JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (04) :297-304
[8]   Mechanism of action of flibanserin in the learned helplessness paradigm in rats [J].
Borsini, F ;
Cesana, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 433 (01) :81-89
[9]   Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain.: Role of α-adrenoceptors [J].
Bortolozzi, A ;
Artigas, F .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (03) :421-434
[10]   AMPHETAMINE-INDUCED DOPAMINE RELEASE IN THE RAT STRIATUM - AN INVIVO MICRODIALYSIS STUDY [J].
BUTCHER, SP ;
FAIRBROTHER, IS ;
KELLY, JS ;
ARBUTHNOTT, GW .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (02) :346-355